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• It was estimated that more than 339 
million people suffer from 
asthma. Asthma is the most common 
noncommunicable disease among 
children. Most deaths occur in older 
adults (WHO, 2019)
• Asthma continues to increase in 
prevalence and is one of the most 
common lung disorders seen and 
treated in the healthcare setting 
(Fehrenbach, Wagner, and Wegmann 





• A heterogeneous disease, usually 
characterized by chronic airway 
inflammation. It is defined by the 
history of respiratory symptoms such as 
wheeze, shortness of breath, chest 
tightness, and cough that vary over time 
and in intensity, together with variable 








• Understanding the pathophysiology of Asthma is important as it can allow the 
practitioners and patients avoid certain triggers and help manage symptoms when an 
asthma exacerbation occurs 
• Understanding the pathologic process allows practitioners to develop the right treatment 
and therapeutic interventions 
• Asthma is thought to have two phenotypes; gradual onset and sudden onset. Depending 
on the phenotype, the response to interventions may be different. For example, in gradual 
onset there is mucus plugging in the airway, and a slower response to treatment. Sudden 
onset typically does not have mucus plugging, and responds more rapidly to treatment 
(Restrepo, et al, p 522).
Pathophysiology
• Asthma is thought to be multi-
factorial and can be influenced by not 
only pathological triggers, but also, 
environmental triggers. 
• The chronic inflammatory 
environment in asthma is 
characterized by chemokines 
interacting with G-protein-coupled 
receptors on target leucocytes.1 
However, four atypical chemokine 
receptors have been described which 
lack the structural components to 
induce downstream signalling2 and 
are thought to regulate inflammatory 
responses by acting as chemokine 
decoys or scavengers (Chapman et. Al, 
2017, p.  1214)
• Asthma is a chronic inflammatory 
disease, which is characterized by 
airway hyper-responsiveness leading 
to intermittent, repeated bouts of 
wheezing, chest tightness, 
breathlessness and coughing (Sullivan 
et., al, 2016, p. 4)
• Asthma has a complex heterogeneity 
with many clinical phenotypes whose 
varying expression depends on 
interplay between numerous 
environmental factors along with 
many different susceptibility genes 
(Sullivan et al,  2016, p. 4)
• The airway epithelium is pivotal in the 
inflammatory response of the host 
and is a major source of 
proinflammatory mediators [33]. TH2 
cells subsequently play a prominent 
role in allergic disorder pathogenesis 
leading to B cells isotype switching, 
generating IgE antibodies which are 
specific to the particular insulting
allergen [8]. TH2 cells further enlist 
and enhance survival of eosinophils 
and mast cells, induce goblet cell 
hyperplasia and further drive 
bronchial hyper reactivity (Sullivan et 
al, 2016, p. 4)
• Causes	can	be	influenced	by	both	
genetic	and	environmental	causes	
• The airway obstruction which 
characterizes the clinical presentation 
of asthma runs in cycles of symptom 
free periods followed by varying 
periods of exacerbation to which 
there is usually a trigger or stimuli. 
These exacerbations result in a 
worsening in symptoms and lung 
function and although is generally 
reversible and followed by a return to 
normal lung function, in some patients 
repeated exacerbations may lead to a 
new, compromised baseline.  (Sullivan 
et al, 2016, p. 4)




• Shortness of Breath






• Any combination of these symptoms
• Evaluation of peak flow may be 
useful during asthma exacerbation, 
but only if patient’s individualized 
peak flow baseline is current and 
known during the time of treatment 













• Use of mechanical ventilation is 
indicated when other therapies fail to 
improve the patient’s symptoms and 
the patient has had a decrease in 
respiratory effort, change in mental 
status, or exhibits hypercapnia and 








• Apply oxygen to patient to achieve a SPO2 >92% 
• Upright positioning to allow for proper gas exchange and elimination 
• Effective communication to patient to ensure proper breathing technique
• Use of nebulizer, inhaler and spacer device.
• Oxygen titrated to maintain SpO2 of >92%. 






















• However, approximately 10 to 30% of patients may still 
require positive pressure ventilation for severe acute asthma 
and mortality could be as high as 22% (Restrepo, et al, p532).
• This understanding will allow for early intervention in asthma 
issues that will lead to positive outcomes for the patients 
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